Biological
Enokizumab clinical trials
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2004
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 0
Studies
Open first, then newest update. How each study uses enokizumab is read from its arms, and is right about nine times in ten.
Testing it · 7
- A Study to Evaluate the Effectiveness and Safety of MEDI-528 in AdultsCompletedPhase 2MedImmune LLCNCT00968669Written as MEDI528 30 mg
- A Phase 2A Study to Evaluate the Safety and Effect on Exercise Challenge Testing of MEDI-528 in Adults With AsthmaTerminatedPhase 2MedImmune LLCNCT00590720Written as MEDI528 50 mg
- A Study to Evaluate the Effect of a Single-Dose Intravenous Administration of MEDI-528TerminatedPhase 2MedImmune LLCNCT00483041Written as MEDI528 9 mg/kg
- Study to Evaluate the Safety, Tolerability,Immunogenicity, and Pharmacokinetics of MEDI-528 in Healthy Adult VolunteersCompletedPhase 1MedImmune LLCNCT00192296Written as MEDI-528 0.3 mg/kg
- A Study to Evaluate the Safety and Tolerability of the Administration of MEDI-528 When Administered in Multiple Doses to Adults With Mild Persistent AsthmaCompletedPhase 2MedImmune LLCNCT00507130Written as MEDI528 0.3 mg/kg
- Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single-Dose Subcutaneous Administration of MEDI-528CompletedPhase 1MedImmune LLCNCT00116168Written as MEDI-528 0.3 mg/kg
- A Study to Evaluate the Efficacy of MEDI-528 on Late Asthmatic Response With Atopic AsthmaCompletedPhase 2MedImmune LLCNCT00394654Written as MEDI-528 9 mg/kg
Codes
What other systems call enokizumab · ClinicalTrials.gg INT005464
- MeSH (NLM) C542276enokizumabOne source NLM
- UNII (FDA) I4BE5F78HRENOKIZUMABConfirmed FDA, NLM, Wikidata
- Wikidata Q5379375EnokizumabConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C97929EnokizumabOne source FDA
- DrugBank DB05555One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C542276 | enokizumab | One source NLM |
| UNII (FDA) | I4BE5F78HR | ENOKIZUMAB | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q5379375 | Enokizumab | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C97929 | Enokizumab | One source FDA |
| DrugBank | DB05555 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.